dihexa peptidomimetic (PNB-0408) | c-Met/HGFR Activator dihexa peptidomimetic Peptide Therapy |

The more you take it, the less you should need and be able to spread out treatments

doi:10.1038/s44294-026-00128-9

Damage to the myelin is why you see neurological abnormalities in B12 deficiency and PA patients

Body Protection Compound-157 (BPC-157) This peptide is promoted for musculoskeletal healing, though most evidence comes from animal and laboratory studies it is lacking large, high-quality human clinical trials

The adverse effects associated with this compounded medication primarily reflect those observed with semaglutide, as cyanocobalamin is generally well-tolerated with minimal side effects when administered at therapeutic doses